John W. Smither, Chief Financial Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 4,200 shares at $46.99 ($202K) on 2015-03-05, disclosed to the SEC on 2015-03-05.
Scheduled sale ($202k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.99 | 2,000 | $94K | 46.5% |
| 2 | $48.00 | 1,000 | $48K | 23.8% |
| 3 | $50.00 | 1,200 | $60K | 29.7% |
| Total | $48.09 avg | 4,200 | $202K | 100% |
| Filing → |
| GNLX | SELL | 2023-09-14 | $19K | — | Filing → |
| ARQT | SELL | 2021-03-11 | $58K | — | Filing → |
| ARQT | SELL | 2021-03-03 | $26K | — | Filing → |